Clinical Trial Update: Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) [Phase 3]

View source ↗

Summary

Phase 3 STRATO trial evaluating switching kidney transplant patients with tremor to LCP-Tacro (tacrolimus) completed and results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• LCP-Tacro (tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure, Tremors | Phase 3 | Status: COMPLETED | Results posted: 2015-05-08